Compounds > ciprofloxacin

ciprofloxacin and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin

ciprofloxacin has been researched along with 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bera, S; Mondal, D1
Akaki, T; Kajitani, H; Sato, K; Shishido, S; Tomioka, H1

Reviews

1 review(s) available for ciprofloxacin and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin

ArticleYear
Insights of synthetic analogues of anti-leprosy agents.
    Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13

    Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship

2019

Other Studies

1 other study(ies) available for ciprofloxacin and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin

ArticleYear
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: 4-Quinolones; Aminopyridines; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Rifamycins

2000